Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    7674315 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers
Conditions: Colorectal Neoplasm;   Hereditary Nonpolyposis
Intervention: Drug: Celecoxib (SC-58635)

Study has passed its completion date and status has not been verified in more than two years.